Latest news
Researchers discovered replication hubs for human norovirus
Researchers have reported the discovery of replication hubs for human norovirus, which could lead to designing antiviral drugs to prevent, control or treat these infections.
Seasonal flu vaccine study reveals host genetics’ role in vaccine response
Scientists have found that influenza subtype-bias is primarily driven by host genetics, particularly major histocompatibility complex (MHC) class-II polymorphisms, with prior exposure playing a secondary role.
Potentially harmful bacteria slip through antimicrobial showerheads
Researchers report that antimicrobial silver-containing showerheads are no ’silver bullet’. In real-world showering conditions, most microbes aren’t exposed to the silver long enough to be killed.
Evolutionary study reveals the toxic reach of disease-causing bacteria across the plant kingdom
The capacity of bacteria to spread disease across the plant kingdom may be much more widespread than previously suspected, according to a comparative evolutionary analysis, using the diversity of Pseudomonas syringae bacteria.
Capybaras found dead from rabies on island in Brazil
The viral rabies strain found in the dead animals on Anchieta Island in Ubatuba was the variant transmitted by vampire bats, which probably fed on the capybaras’ blood at a time of habitat disturbance.
The surprising role of gut infection in Alzheimer’s disease
A new study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral treatments.
Researchers discovered replication hubs for human norovirus
Researchers have reported the discovery of replication hubs for human norovirus, which could lead to designing antiviral drugs to prevent, control or treat these infections.
Seasonal flu vaccine study reveals host genetics’ role in vaccine response
Scientists have found that influenza subtype-bias is primarily driven by host genetics, particularly major histocompatibility complex (MHC) class-II polymorphisms, with prior exposure playing a secondary role.
Potentially harmful bacteria slip through antimicrobial showerheads
Researchers report that antimicrobial silver-containing showerheads are no ’silver bullet’. In real-world showering conditions, most microbes aren’t exposed to the silver long enough to be killed.
Start-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
Breakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
New collaboration aims to optimize nutrient uptake and tolerance to environmental stress with crop boosting fungi
A joint program to develop methods to accelerate and optimize the in vitro growth of AMF (arbuscular mycorrhizal fungi) for more sustainable agriculture has been announced.
Tinkering with the ‘clockwork’ mechanisms of life
Scientists have successfully recreated and validated two distinct mechanisms that can program both the activation and deactivation rates of nanomachines in living organisms across multiple timescales.
Bio-electrochemical cell producing hydrogen from microorganisms in waste: Pathway to large-scale implementation unveiled
Scientists have achieved a significant breakthrough in clean energy technology, successfully enhancing a crucial component of a bio-electrochemical cell and enabling more efficient hydrogen production from microorganisms found in waste.
Probiotics with a protective armor: New method boosts survival and gut health
A research team has developed a new method for encapsulating probiotics, using nanoparticles formed by antisolvent precipitation to protect the probiotics.
Start-up EBViously announces its launch
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a preventive vaccine against diseases caused by the Epstein-Barr virus (EBV).
Royal Veterinary College awarded international grants to advance research into cattle vaccines
The Royal Veterinary College (RVC) has been awarded two pump-prime grants from the International Veterinary Vaccinology Network (IVVN) to advance crucial research into Bovine Babesiosis and Bovine Tuberculosis vaccines to support cattle welfare.
New guidelines unveil advanced strategies for HIV treatment and prevention
The International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international guidelines for the treatment and prevention of HIV, based on significant advances in antiretroviral therapies and new prevention strategies such as pre-exposure prophylaxis.
